These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12877389)

  • 1. Vysis UroVysion for the detection of urothelial carcinoma.
    Halling KC
    Expert Rev Mol Diagn; 2003 Jul; 3(4):507-19. PubMed ID: 12877389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
    Halling KC; King W; Sokolova IA; Karnes RJ; Meyer RG; Powell EL; Sebo TJ; Cheville JC; Clayton AC; Krajnik KL; Ebert TA; Nelson RE; Burkhardt HM; Ramakumar S; Stewart CS; Pankratz VS; Lieber MM; Blute ML; Zincke H; Seelig SA; Jenkins RB; O'Kane DJ
    J Urol; 2002 May; 167(5):2001-6. PubMed ID: 11956427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder cancer detection using FISH (UroVysion assay).
    Halling KC; Kipp BR
    Adv Anat Pathol; 2008 Sep; 15(5):279-86. PubMed ID: 18724101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicolor FISH (UroVysion) facilitates follow-up of patients with high-grade urothelial carcinoma of the bladder.
    Fritsche HM; Burger M; Dietmaier W; Denzinger S; Bach E; Otto W; Doblinger M; Schwarz S; Buchner H; Hartmann A
    Am J Clin Pathol; 2010 Oct; 134(4):597-603. PubMed ID: 20855641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified UroVysion scoring criteria increase the urothelial carcinoma detection rate in cases of equivocal urinary cytology.
    Huysentruyt CJ; Baldewijns MM; Rüland AM; Tonk RJ; Vervoort PS; Smits KM; van de Beek C; Speel EJ
    Histopathology; 2011 Jun; 58(7):1048-53. PubMed ID: 21707706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of fluorescence in situ hybridization, mtDNA quantification, and mtDNA sequence for the detection of early bladder cancer.
    Yoo JH; Suh B; Park TS; Shin MG; Choi YD; Lee CH; Choi JR
    Cancer Genet Cytogenet; 2010 Apr; 198(2):107-17. PubMed ID: 20362225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
    Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
    Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
    Moonen PM; Merkx GF; Peelen P; Karthaus HF; Smeets DF; Witjes JA
    Eur Urol; 2007 May; 51(5):1275-80; discussion 1280. PubMed ID: 17084511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of fluorescence in situ hybridization of urine exfoliative cells in diagnosis of urinary bladder neoplasms].
    Chen N; Gong J; Zeng H; Wei Q; Zhu YC; Chen M; Zhou Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):109-13. PubMed ID: 21355314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients.
    Chuang KL; Chuang HC; Ng KF; Chang YH; Wu CT; Chuang CK; Liao SK; Pang ST
    BJU Int; 2010 May; 105(10):1413-6. PubMed ID: 19818076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer.
    Arentsen HC; de la Rosette JJ; de Reijke TM; Langbein S
    Expert Rev Mol Diagn; 2007 Jan; 7(1):11-9. PubMed ID: 17187480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma: a "split-sample" study.
    Sullivan PS; Nooraie F; Sanchez H; Hirschowitz S; Levin M; Rao PN; Rao J
    Cancer; 2009 Jun; 117(3):167-73. PubMed ID: 19365828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings.
    Yoder BJ; Skacel M; Hedgepeth R; Babineau D; Ulchaker JC; Liou LS; Brainard JA; Biscotti CV; Jones JS; Tubbs RR
    Am J Clin Pathol; 2007 Feb; 127(2):295-301. PubMed ID: 17210520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate-risk urothelial carcinoma: an unresolved problem?
    Pycha A; Lodde M; Comploj E; Negri G; Egarter-Vigl E; Vittadello F; Lusuardi L; Palermo S; Mian C
    Urology; 2004 Mar; 63(3):472-5. PubMed ID: 15028440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiprobe fluorescence in situ hybridization (UroVysion) for the detection of urothelial carcinoma - FISHing for the right catch.
    Bubendorf L
    Acta Cytol; 2011; 55(2):113-9. PubMed ID: 21325794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.
    Halling KC; King W; Sokolova IA; Meyer RG; Burkhardt HM; Halling AC; Cheville JC; Sebo TJ; Ramakumar S; Stewart CS; Pankratz S; O'Kane DJ; Seelig SA; Lieber MM; Jenkins RB
    J Urol; 2000 Nov; 164(5):1768-75. PubMed ID: 11025767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.
    Bubendorf L; Grilli B; Sauter G; Mihatsch MJ; Gasser TC; Dalquen P
    Am J Clin Pathol; 2001 Jul; 116(1):79-86. PubMed ID: 11447756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
    Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
    Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.